The Global Veterinary Biologics Market is set for substantial growth, with an estimated valuation of USD 13,140.6 million in 2024, projected to surpass USD 24,224.3 million by 2034, at a CAGR of 6.3%. The market is driven by the rising demand for companion animal biologics, emergence of new infectious diseases, and increased global trade in animal products.
Request a Sample Report Now to get Premium Insights: https://www.futuremarketinsights.com/report-sample#5245502d47422d32323838
Key Market Drivers:
- Rising Demand for Companion Animal Biologics: Growing pet ownership, especially of dogs, cats, and horses, has boosted the demand for specialized biologics targeting companion animal healthcare.
- Emergence of New Infectious Diseases: Evolving animal diseases like avian influenza and African swine fever necessitate the development of specific vaccines and biologics for prevention and control.
- Globalization of Animal Trade: International trade regulations and the need for disease-free animal products are driving the adoption of veterinary biologics to maintain animal health standards.
- Preventive Healthcare Awareness: Education campaigns and training programs are increasing awareness among veterinarians, farmers, and pet owners about the benefits of preventive healthcare, promoting the adoption of veterinary biologics.
Market Trends and Applications:
- Specialized Vaccines and Biologics: Increased focus on species-specific vaccines for companion animals and livestock is gaining momentum, enhancing targeted disease prevention.
- Innovative Biologics Development: Advancements in biotechnology are driving the development of recombinant vaccines, monoclonal antibodies, and gene therapy solutions for animal healthcare.
- Regulatory Support and R&D Investment: Favorable regulatory frameworks and increased R&D investments are supporting innovation in veterinary biologics, ensuring efficacy and safety.
- Pet Insurance and Healthcare Expenditure: Rising pet insurance coverage and increased spending on pet healthcare are positively impacting the veterinary biologics market.
Key Takeaways:
- The Veterinary Biologics Market is expected to grow at a CAGR of 6.3% from 2024 to 2034, reaching USD 24.22 billion by 2034.
- Companion animal biologics and species-specific vaccines are driving market demand.
- Emerging infectious diseases and global animal trade are increasing the need for preventive veterinary biologics.
- Innovative biotechnology solutions and recombinant vaccines are gaining popularity.
- Leading companies are investing in R&D and adopting competitive strategies to strengthen their market position.
Access the Full Report: https://www.futuremarketinsights.com/reports/veterinary-biologics-market
Competitive Landscape:
The veterinary biologics market is highly competitive, with major players focusing on product differentiation, expansion strategies, and mergers and acquisitions to enhance market presence. Key manufacturers are also emphasizing disease-specific vaccine development to address emerging health challenges.
Key Veterinary Biologics Market Players
- Elanco Animal Health
- Ceva
- Phibro Animal Health Corporation
- Boehringer Ingelheim
- Zoetis Inc.
- Merck & Co. Inc.
- Virbac
- Hester Biosciences Limited
- Colorado Serum Company
- Addison Biological Laboratory Inc.
- American Animal Health Inc.
- HIPRA
- Bimeda Inc. (Texas Vet Lab Inc.)
Key Segments in the Veterinary Biologics Market Report
By Product:
- Vaccines
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Bacterial Extracts
- Monoclonal Antibody
- Immunomodulatory
- Cytokines
- Others
- Allergenic Extracts
By Animal:
- Companion Animals
- Canine
- Avian
- Feline
- Livestock
- Aquatic
- Bovine
- Porcine
- Ovine/Caprine
- Poultry
- Equine
By Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centres in the United Kingdom, the United States, and India. FMI’s latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.
Contact Us
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
